Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/39028
Type
ArticleCopyright
Open access
Collections
- ENSP - Artigos de Periódicos [2412]
Metadata
Show full item record
FACTORS ASSOCIATED WITH PHARMACEUTICAL EXPENDITURES BY ELDERLY PEOPLE IN BELO HORIZONTE, BRAZIL
Author
Affilliation
Universidade Federal de Minas Gerais. Faculdade de Farmácia. Departamento de Farmácia Social. Belo Horizonte, MG, Brasil.
Universidade Federal de Viçosa. Departamento de Nutrição e Saúde. Viçosa, MG, Brasil.
Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sergio Arouca. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sergio Arouca. Rio de Janeiro, RJ, Brasil.
Universidade Federal de Minas Gerais. Faculdade de Farmácia. Departamento de Farmácia Social. Belo Horizonte, MG, Brasil.
Universidade Federal de Viçosa. Departamento de Nutrição e Saúde. Viçosa, MG, Brasil.
Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sergio Arouca. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sergio Arouca. Rio de Janeiro, RJ, Brasil.
Universidade Federal de Minas Gerais. Faculdade de Farmácia. Departamento de Farmácia Social. Belo Horizonte, MG, Brasil.
Abstract
A study was carried out to analyze the factors associated with drug spending by the elderlypopulation in Belo Horizonte, Brazil. Data were obtained using a household survey of 667 community-dwelling persons aged 60 years or older conducted in 2003. A Tobit multivariate model was used to ana-lyze factors associated with pharmaceutical expenditures. Data from 590 respondents were used for theanalysis. The mean out-of-pocket pharmaceutical expenditure was US$ 38.91. Better sociodemographicconditions, worse health conditions and greater use of health services were associated with out-of-pocketpharmaceutical expenditures by elderly people in Belo Horizonte. The out-of-pocket pharmaceutical ex-penditures by elderly people were high considering their income level. The factors that influence spendingshould be considered in the formulation of pharmaceutical policies that improve the health conditions ofelderly people.
Share